IRIS- DESyne X2 in the IRIS-DES Registry

NCT ID: NCT03588481

Last Updated: 2024-12-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-28

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Stenosis Coronary Occlusion Coronary Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

PCI DES real world

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Coronary stenosis

DESyne X2

Intervention Type DEVICE

Novolimus-eluting stent

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

DESyne X2

Novolimus-eluting stent

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 19 and more
* Intervention with DeSyne X2 drug-eluting coronary stent
* Agreed with written informed consent form

Exclusion Criteria

* Intervention with DeSyne X2 drug-eluting coronary stent and other drug eluting stent at the same time
* Life expectancy of 1year and under
* Cardiac shock
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seung-Jung Park

OTHER

Sponsor Role lead

CardioVascular Research Foundation, Korea

OTHER

Sponsor Role collaborator

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Seung-Jung Park

Professor, Division of Cardiology, Department of Medicine, Heart Institute, Asan Medical Center, University of Ulsan College of Medicine

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hallym Hospital

Incheon, , South Korea

Site Status RECRUITING

Asan Medical Hospital

Seoul, , South Korea

Site Status RECRUITING

Korea University Guro Hospital

Seoul, , South Korea

Site Status RECRUITING

The Catholic University of Korea Seoul St. Mary's Hospital

Seoul, , South Korea

Site Status WITHDRAWN

The Catholic University of Korea, Eunpyeong St. Mary's Hospital

Seoul, , South Korea

Site Status TERMINATED

St.carollo Hospital

Suncheon, , South Korea

Site Status TERMINATED

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jung-hee Ham, RN

Role: CONTACT

Phone: 82230104728

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Soo-han Kim, MD

Role: primary

Seung-jung Park, MD

Role: primary

SEUNG-UN NA, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AMCCV2018-09

Identifier Type: -

Identifier Source: org_study_id